| PERIOD ENDING | 27-Jun-08 | 28-Mar-08 | 28-Dec-07 | 28-Sep-07 | | Total Revenue | 2,907,000 | 2,713,000 | 2,577,000 | 2,501,000 | | Cost of Revenue | 2,356,000 | 1,249,000 | 3,213,000 | 46,000 | | | Gross Profit | 551,000 | 1,464,000 | (636,000) | 2,455,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (395,000) | 618,000 | (1,457,000) | 1,681,000 | | Non Recurring | 2,000 | (2,000) | (8,000) | (1,000) | | Others | 227,000 | 222,000 | 220,000 | 220,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 717,000 | 626,000 | 609,000 | 555,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | 55,000 | 58,000 | 35,000 | | Earnings Before Interest And Taxes | 723,000 | 681,000 | 685,000 | 572,000 | | Interest Expense | 133,000 | 119,000 | 115,000 | 102,000 | | Income Before Tax | 590,000 | 562,000 | 570,000 | 470,000 | | Income Tax Expense | 205,000 | 211,000 | 205,000 | 173,000 | | Minority Interest |
-
|
-
| 18,000 | (18,000) | | | | Net Income From Continuing Ops | 385,000 | 351,000 | 365,000 | 297,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 110,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 385,000 | 351,000 | 365,000 | 407,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $385,000 | $351,000 | $365,000 | $407,000 |
|
1.49% Nasdaq 0.00%
Income Statement
